MAM
McLean Asset Management’s Thermo Fisher Scientific TMO Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $256K | Buy |
599
+8
| +1% | +$3.42K | 0.07% | 142 |
|
|
2025
Q1 | $248K | Sell |
591
-18
| -3% | -$7.55K | 0.08% | 128 |
|
|
2024
Q4 | $317K | Sell |
609
-12
| -2% | -$6.24K | 0.1% | 108 |
|
|
2024
Q3 | $372K | Buy |
621
+6
| +1% | +$3.59K | 0.11% | 92 |
|
|
2024
Q2 | $330K | Sell |
615
-91
| -13% | -$48.9K | 0.11% | 95 |
|
|
2024
Q1 | $416K | Sell |
706
-2
| -0.3% | -$1.18K | 0.14% | 83 |
|
|
2023
Q4 | $376K | Sell |
708
-60
| -8% | -$31.9K | 0.14% | 80 |
|
|
2023
Q3 | $381K | Buy |
768
+36
| +5% | +$17.9K | 0.16% | 78 |
|
|
2023
Q2 | $382K | Buy |
732
+7
| +1% | +$3.65K | 0.15% | 81 |
|
|
2023
Q1 | $418K | Sell |
725
-21
| -3% | -$12.1K | 0.17% | 73 |
|
|
2022
Q4 | $411K | Sell |
746
-42
| -5% | -$23.1K | 0.14% | 78 |
|
|
2022
Q3 | $413K | Sell |
788
-5
| -0.6% | -$2.62K | 0.16% | 64 |
|
|
2022
Q2 | $441K | Buy |
793
+8
| +1% | +$4.45K | 0.18% | 62 |
|
|
2022
Q1 | $464K | Buy |
785
+21
| +3% | +$12.4K | 0.34% | 55 |
|
|
2021
Q4 | $478K | Sell |
764
-174
| -19% | -$109K | 0.18% | 59 |
|
|
2021
Q3 | $571K | Buy |
938
+10
| +1% | +$6.09K | 0.22% | 49 |
|
|
2021
Q2 | $483K | Buy |
928
+20
| +2% | +$10.4K | 0.22% | 50 |
|
|
2021
Q1 | $445K | Hold |
908
| – | – | 0.35% | 46 |
|
|
2020
Q4 | $423K | Buy |
+908
| New | +$423K | 0.37% | 44 |
|